1. Home
  2. SAM vs TNGX Comparison

SAM vs TNGX Comparison

Compare SAM & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Beer Company Inc. (The)

SAM

Boston Beer Company Inc. (The)

HOLD

Current Price

$163.00

Market Cap

2.5B

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$21.37

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAM
TNGX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SAM
TNGX
Price
$163.00
$21.37
Analyst Decision
Hold
Strong Buy
Analyst Count
11
10
Target Price
$233.70
$21.78
AVG Volume (30 Days)
265.7K
2.6M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
95.45
26.89
EPS
N/A
N/A
Revenue
$1,964,994,000.00
$62,384,000.00
Revenue This Year
$1.02
N/A
Revenue Next Year
$1.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.29
52 Week Low
$162.31
$3.12
52 Week High
$264.46
$28.41

Technical Indicators

Market Signals
Indicator
SAM
TNGX
Relative Strength Index (RSI) 25.73 47.47
Support Level N/A $20.05
Resistance Level $228.42 $22.01
Average True Range (ATR) 6.96 1.71
MACD -0.39 -0.02
Stochastic Oscillator 3.66 30.36

Price Performance

Historical Comparison
SAM
TNGX

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: